Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 2NHW9AKY9C

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-6 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lupus Erythematosus, Systemic 2 D008180 ClinicalTrials
Crohn Disease 2 D003424 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109613
FDA SRS 2NHW9AKY9C